Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for HEPATITIS B SURFACE ANTIGEN

Ingredient

HEPATITIS B SURFACE ANTIGEN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
ENGERIX-B	20MCG	SUSPENSION	Resolved	2017-04-11	2019-12-10	6511
ENGERIX-B	10MCG	SUSPENSION	Resolved	2019-02-08	2019-07-26	75189
ENGERIX-B	10MCG	SUSPENSION	Resolved	2021-06-28	2021-07-20	141615
ENGERIX-B	10MCG	SUSPENSION	Resolved	2022-03-15	2022-04-13	156738
ENGERIX-B	10MCG	SUSPENSION	Resolved	2022-10-07	2022-10-13	171261
ENGERIX-B	10MCG	SUSPENSION	Resolved	2023-03-10	2023-04-28	186642
ENGERIX-B	10MCG	SUSPENSION	Resolved	2024-06-14	2024-09-06	230537
ENGERIX-B	10MCG	SUSPENSION	Resolved	2024-10-04	2024-10-25	239471
ENGERIX-B	10MCG	SUSPENSION	Resolved	2025-09-12	2025-10-11	267093
ENGERIX-B	20MCG	SUSPENSION	Resolved	2020-02-03	2020-03-25	105174

1
2
3
4
Next

Showing 1 to 10 of 36

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
ENGERIX-B	20MCG	SUSPENSION	Discontinued	2019-12-10	2020-05-27	100904
ENGERIX-B	10MCG	SUSPENSION	Discontinued	2019-12-10	2020-04-30	100907
RECOMBIVAX HB	10MCG	SUSPENSION SOLUTION	To be discontinued	2026-03-27	2026-04-01	281666
RECOMBIVAX HB	10MCG	SUSPENSION SOLUTION	Discontinued	2026-03-27	2026-04-18	281670
RECOMBIVAX HB	10MCG	SUSPENSION SOLUTION	To be discontinued	2026-03-27	2026-04-01	281676

1

Showing 1 to 5 of 5